Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Bile acid receptor | ||
Ligand | BDBM21723 | ||
Substrate/Competitor | BDBM10852 | ||
Meas. Tech. | Cotransfection Assay | ||
pH | 7.2±n/a | ||
Temperature | 310.15±n/a K | ||
EC50 | 3700±n/a nM | ||
Comments | Antagonist activity. | ||
Citation | Kainuma, M; Makishima, M; Hashimoto, Y; Miyachi, H Design, synthesis, and evaluation of non-steroidal farnesoid X receptor (FXR) antagonist. Bioorg Med Chem15:2587-600 (2007) [PubMed] Article | ||
More Info.: | Get all data from this article, Solution Info, Assay Method | ||
Bile acid receptor | |||
Name: | Bile acid receptor | ||
Synonyms: | BAR | Bile acid receptor FXR | FXR | Farnesol receptor HRR-1 | HRR1 | NR1H4 | NR1H4_HUMAN | Nuclear receptor subfamily 1 group H member 4 | RIP14 | RXR-interacting protein 14 | Retinoid X receptor-interacting protein 14 | farnesoid x receptor | ||
Type: | Nuclear Receptor | ||
Mol. Mass.: | 55916.24 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q96RI1 | ||
Residue: | 486 | ||
Sequence: |
| ||
BDBM21723 | |||
BDBM10852 | |||
Name | BDBM21723 | ||
Synonyms: | 3-[(2-chloro-4-{[3-(2,6-dichlorophenyl)-5-(4-phenylphenyl)-1,2-oxazol-4-yl]methoxy}benzene)amido]benzoic acid | Isoxazole derivative, 15h | ||
Type | Small organic molecule | ||
Emp. Form. | C36H23Cl3N2O5 | ||
Mol. Mass. | 669.937 | ||
SMILES | OC(=O)c1cccc(NC(=O)c2ccc(OCc3c(noc3-c3ccc(cc3)-c3ccccc3)-c3c(Cl)cccc3Cl)cc2Cl)c1 |(12.61,-2.96,;11.28,-2.19,;11.28,-.65,;9.95,-2.96,;9.95,-4.5,;8.61,-5.27,;7.28,-4.5,;7.28,-2.96,;5.95,-2.19,;4.61,-2.96,;4.61,-4.5,;3.28,-2.19,;3.28,-.65,;1.95,.12,;.61,-.65,;-.29,.6,;-1.82,.44,;-2.73,1.68,;-4.27,1.68,;-4.75,3.15,;-3.5,4.05,;-2.25,3.15,;-.79,3.62,;-.5,5.13,;.96,5.64,;2.12,4.63,;1.83,3.11,;.37,2.61,;3.58,5.13,;3.58,6.67,;4.91,7.44,;6.25,6.67,;6.25,5.13,;4.91,4.36,;-5.18,.44,;-6.65,.88,;-7,2.38,;-7.77,-.17,;-7.42,-1.67,;-5.95,-2.12,;-4.82,-1.06,;-3.35,-1.51,;.61,-2.19,;1.95,-2.96,;1.95,-4.5,;8.61,-2.19,)| | ||
Structure |